Trial no.:
|
PACTR201706002388985 |
Date of Approval:
|
28/06/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Erector spinae plan block |
Official scientific title |
Ultrasound-guided erector spinae block in patients undergoing laparoscopic bariatric surgery |
Brief summary describing the background
and objectives of the trial
|
Despite the minimally invasive nature of LGBS, pain can be moderate to severe in the immediate postoperative period. Further, pain control in the morbidly obese can be especially challenging because of increased sensitivity to opioid-induced respiratory depression. Ultrasound-guided erector spinae plane block (ESPB) is a recently described technique for providing thoracic analgesia. Cadaveric investigation indicates that injection of 20ml solution into the fascial plane deep to the erector spinae muscle at the level of T5 transverse process can result in injectate spread between the C7 and T8 vertebral levels. Given that the erector spinae muscle extends inferiorly to the lumbar spine, injection into the erector spinae plane (ESP) at a lower vertebral level(eg T7 or T8) should result in spread to the lower thoracoabdominal nerves that innervate the abdomen. In addition, because the mechanism of action of the ESPB involves penetration of local anesthetic into the thoracic paravertebral space, it anesthetizes not only the ventral rami of spinal nerves but also the rami communicantes that contain sympathetic nerve fibers. The ESPB thus has the potential to provide both somatic and visceral sensory blockade which would make it an ideal regional anesthetic technique for abdominal surgery. The aim of the present study will be to evaluate the analgesic efficacy of ESPB in morbid obese patients undergoing laparoscopic bariatric surgery. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Postoperative pain |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/05/2017 |
Actual trial start date |
05/08/2017 |
Anticipated date of last follow up |
01/11/2017 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Completed |
Publication URL |
|
|